Pretreatment of DLD-1 intestinal cells with sialidase significantly reduced EV71 replication by 20-fold (p < 0.01), demonstrating that SA-linked glycans act as receptors for EV71 infection.
Does treatment with SA-linked glycans or sialidase prevent EV71 infection in DLD-1 intestinal cells?
Sialylated glycans act as receptors for EV71 in intestinal cells, and natural SA-linked glycans from human milk can inhibit EV71 infection in vitro.
Effect estimate: 20-fold reduction
Absolute Event Rate: 70000% vs 1700000%
p-value: p=<0.01
BACKGROUND: Many viruses recognize specific sugar residues, particularly sulfated or sialylated glycans, as the infection receptors. A change of sialic acid (2-6)-linked galactose (SA-alpha2,6Gal) to SA-alpha2,3Gal determines the receptor for avian flu infection. The receptor for enterovirus 71 (EV71) infection that frequently causes fatal encephalitis in Asian children remains unclear. Currently, there is no effective vaccine or anti-virus agent for EV71 infection. Using DLD-1 intestinal cells, this study investigated whether SA-linked glycan on DLD-1 intestinal cells was a receptor for EV71, and whether natural SA-linked sugars from human milk could block EV71 infection. RESULTS: EV71 specifically infected DLD-1 intestinal cells but not K562 myeloid cells. Depletion of O-linked glycans or glycolipids, but not N-linked glycans, significantly decreased EV71 infection of DLD-1 cells. Pretreatment of DLD-1 cells with sialidase (10 mU, 2 hours) significantly reduced 20-fold EV71 replication (p < 0.01). Taken together, these results suggest that SA-linked O-glycans and glycolipids, but not N-glycans, on DLD-1 cells were responsible for EV71 infection. Purified SA-alpha2,3Gal and SA-alpha2,6Gal from human milk significantly inhibited EV71 infection of DLD-1 cells, indicating terminal SA-linked glycans could be receptors and inhibitors of EV71 infection. CONCLUSION: This is the first in the literature to demonstrate that EV71 uses SA-linked glycans as receptors for infection, and natural SA-linked glycans from human milk can protect intestinal cells from EV71 infection. Further studies will test how a SA-containing glycan can prevent EV71 in the future.
Yang et al. (Thu,) conducted a other in Enterovirus 71 (EV71) infection. Sialidase treatment and SA-linked glycans vs. Untreated EV71 infected cells was evaluated on EV71 replication in DLD-1 cells (20-fold reduction, p=<0.01). Pretreatment of DLD-1 intestinal cells with sialidase significantly reduced EV71 replication by 20-fold (p < 0.01), demonstrating that SA-linked glycans act as receptors for EV71 infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: